Main Menu

Imago BioSciences, Inc.

(NASDAQ GS: IMGO)

Rigrodsky Law, P.A. is investigating Imago BioSciences, Inc. (“Imago”) regarding possible breaches of fiduciary duties and other violations of law related to Imago’s agreement to be acquired by Merk Sharp & Dohme LLC.  Under the terms of the agreement, Imago’s shareholders will receive $36.00 per share. 

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 11/21/2022


* Indicates a required field.

Back to Page